These materials include updated recommendations form the New York City Health Department and from the Centers for Disease Control and Prevention (CDC) regarding clinical management of patients with suspected or confirmed influenza during the 2013-14 influenza season. Decisions regarding clinical management of patients should be based on local current surveillance data, patient underlying risk conditions, and severity of illness. In most cases, laboratory diagnostic testing to distinguish whether a patient has influenza or which type or subtype, will not be available in time for clinical decisions. Clinical judgment should always be used. Please consult information on vaccination.
When influenza is circulating in the community:
* Influenza-like illness (ILI) is defined as fever ≥ 100°F (≥ 37.8°C) with cough and/or sore throat
See more information: general clinical management.
Early empiric treatment of ILI (ideally within 48 hours of onset) is recommended for people with severe symptoms, hospitalized patients and those with underlying conditions increasing the risk of complications and severe illness. Treatment may be beneficial even if initiated after 48 hours post-onset. All patients being hospitalized for suspected or confirmed influenza should be treated, regardless of time since onset. Currently, oseltamivir or zanamavir are the drugs of choice to treat suspected or confirmed influenza.
See more information: antiviral treatment and prophylaxis.
Diagnostic testing for influenza is generally not necessary for most patients with mild influenza-like illness.
See more information: